|
|
News Breaks | | | | February 25, 2013 | | 11:21 EDT |  | DRTX | Durata Therapeutics held a conference call
Conference call to discuss preliminary, topline Phase 3 clinical trial results for Dalbavancin in the treatment of ABSSSI was held on February 25 at 8:30 am and has a replay available through March 11, 2013. Webcast Link | |
|
News For DRTX From The Last 14 Days Check below for free stories on DRTX the last two weeks. |
|
|
| There are no results for DRTX |
|
|
|
|
|
|
